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Placental alkaline phosphatase ts an inducible enzyme. expressed in HeLaS3 cells, whrch has been shown to possess protein phosphotyrosme 
phosphatase activity. Since phosphotyrosine levels are known to increase m actively drvrdmg cells we sought an Inverse correlatron between PLAP 
activity and growth rate m HeLaSS cells. We found that PLAP Inducers, Na-butyrate, dexamethasone. bromodeoxyuridme and drbutyryl CAMP 
caused a dose-dependent reduction in growth rate. Mimosine. an agent that blocks the cell cycle m Gl. caused an Increase m PLAP activtty whrlst 
the mrtogen EGF caused a correspondmg decrease m PLAP actrvity. PLAP acttvity may therefore be related to cell prohferation rate 
Placental alkahne phosphatase; Cell growth; Eprdermal growth factor: Mimosine: Gl phase 
1. INTRODUCTION 
The fact that alkaline phosphatase is synthesized so 
ubiquitously in nature. by bacteria, plants and animals, 
indicates that this enzyme is involved in fundamental 
biochemical processes, but its physiological role is not 
yet clear [l]. Alkaline phosphatases (EC 3.1.3.1) com- 
prise a group of enzymes which are classified by their 
ability to participate in hydrolase/transferase reactions 
on a wide range of phosphate containing compounds at 
pH lo-lo.5 [I]. 
In man there are four different alkaline phosphatase 
genes; liver/kidney/bone (tissue-unspecific), intestinal. 
placental and germ cell (placental-like) [2]. each of 
which is expressed in its own tissue-specific pattern. 
Alkaline phosphatase has been found in several organ- 
elles in various species, although in vertebrates it is 
primarily a plasma membrane enzyme [I]. The enzyme 
has been implicated in mammalian bone calcification [3] 
and phosphate transfer in the epithelial cells of the intes- 
tine [4], but the evidence for these roles of the enzyme 
is not conclusive. The lack of substrate specificity and 
the broad spectrum of activities exhibited by alkaline 
phosphatase has rendered the elucidation of the physio- 
logical function of the enzyme very difficult. 
Over the past few years evidence has accumulated 
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In the past is has been shown that in certain human 
cancer cell lines, which express alkaline phosphatase 
activity at low levels, this activity could be increased by 
exposure to a diverse group of agents with no apparent 
similarities in their chemical structure. These alkaline 
phosphatase inducers include glucocorticoids [9], so- 
dium butyrate 191, bromodeoxyuridine [lo] and dibu- 
tyryl CAMP 1111. One such cell line is the HeLaS3 cervi- 
cal cancer cell line. This cell line synthesizes both pla- 
cental and intestinal alkaline phosphatase [11,12]. Bu- 
tyrate and prednisolone (a glucocorticoid) induce PLAP 
activity in these cells [9] and it has also been shown that 
these compounds arrest the cell cycle in Gl [l 1,131. In 
light of evidence of a role for alkaline phosphatase as 
a tyrosine protein phosphatase and the fact that com- 
pounds which increase alkaline phosphatase activity 
may also decrease cell growth rate we decided to deter- 
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which suggests that alkaline phosphatase may possess 
phosphotyrosine phosphatase activity and thus may 
play a role in cell division in both normal and trans- 
formed cells [5]. It has been demonstrated that a variety 
of alkaline phosphatase preparations dephosphorylate 
phosphotyrosyl-histones, at physiological pH, at 5-10 
times the rate observed with phosphoseryl-histones [6]. 
These enzymes were also active against phosphotyrosyl- 
proteins from A43 1 cells [6]. It has also been shown that 
the protein phosphatase activity of liver membranes is 
inhibited by levamisole (a specific alkaline phosphatase 
inhibitor) [7]. These results were interpreted as showing 
that alkaline phosphatase is the major protein phos- 
phatase in liver membranes. Further, it has been shown 
that the characteristics of the enzyme responsible for 
protein phospohatase activity in bone cells correlated 
with those of bone cell alkaline phosphatase [8]. 
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Figure 1 Effect of butyrate on placental alkaline phosphatase activity and cell growth rate of 
HeLaS3 cells. 
80 
I - cell number 
I I I '0 
1 
Concentrat& of butyrate &M) 
4 
Fig. 1 HeLaS3 cells were seeded into 75 cm’ flasks at approx. 9 x IO’ cells/flask and allowed to attach over a 24 h period. They were then grown, 
either in the absence (control) or presence of butyrate. at the indicated concentrations, for 96 h. Cells were then harvested for cell counting and 
for assay of heat-stable alkaline phosphatase activity. The medium was changed every 24 h. The data represent mean 2 S.E.M. of three experiments. 
mine whether there is an inverse correlation between 
PLAP activity and cell growth rate in HeLaS3 cells. 
2. MATERIALS AND METHODS 
2.1. Materrals 
Mimmum Essential Medium (MEM) with Earle’s salts and penicillin/ 
streptomycin was obtained from Gibco/BRL (UK). Foetal calf serum 
was obtained from Imperial Laboratories (UK). All other chemicals 
were obtained from Sigma Chemical Co. except for mlmosine which 
was obtained from Aldrich Chemical Co. 
2.5 Growth of cells WI serum free medium 
Cell monolayers were washed three times with PBS prior to transfer 
to MEM supplemented with BSA (0.2% v/v), transferrin (10 pg/ml). 
sodium selenite (2.6 ng/ml) and antibiotics, at previously described 
concentrations. Cells were grown in this medium for 24 h after which 
time they were grown either in the absence or presence of EGF (20 
ng/ml). 
2.2. CeN &lure 3. RESULTS 
HeLaS3 cells were grown m Mmimum Essential Medium (MEM) 
with Earle’s salts supplemented with 10% foetal calf serum, 100 units/ 
ml penicillin and 100 &ml streptomycin at 37°C in a humidified 
atmosphere of 5% carbon dioxide/95% air. 
3.1. Heat stability of alkaline phosphatase in HeLaS3 
cells 
2.3. Inductron procedures 
Cells were seeded into 75 cm’ flasks at the indicated densities and 
allowed to attach for 24 h before addition of inducing agents. Cell 
counts were made with an Improved Neubauer haemocytometer, on 
trypsinised cells in complete medium. Cell viability was determined by 
trypan blue exclusion 
2.4. Eqme assa) 
Cell monolayers were washed three times with ice-cold PBS (0.14 
M NaCl. 9 mM NaH,PO,, 3 mM KCl, 2 mM KH,PO,; pH 7.2) and 
detached into PBS using a rubber policeman. The cells were pelleted 
by centrifugation at 1000 x g for 5 mm and the pellet was resuspended 
m 0.25% (w/v) sodium deoxycholate, pH 8.0. Alkaline phosphatase 
HeLaS3 cells synthesize two alkaline phosphatase 
isoenzymes, PLAP and intestinal alkaline phosphatase 
[ 11,121. In the past there has been no indication whether 
intestinal alkaline phosphatase is inducible in these 
cells. We decided to study the correlation between 
PLAP activity and cell growth since this isoenzyme is 
documented as being inducible by butyrate and by a 
synthetic glucocorticoid, prednisolone [9]. We initially 
characterized the heat stability at 65°C of alkaline phos- 
phatase activity in our cells, this being an established 
method for distinguishing between heat-stable PLAP 
and heat-labile intestinal alkaline phosphatase activity. 
activity was measured by the release of phenol from phenyl phosphate 
at pH 10.7 at 37°C. Protein was determined using a Lowry protein 
determination kit. Enzyme activities are presented as % of control 
activity (where untreated cell activity was taken to be 100%). 
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Figure 2 Effect of dexamethasone on placental alkaline phosphatase activity and cell growth 
rate of HeLaS3 cells. 
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Fig. 2. HeLaS3 cells were seeded into 75 cm’ flasks at approx 1 x IO’ cells/flask and allowed to attach over a 24 h period. They were then grown. 
either in MEM supplemented with 4% of steroid-stnpped newborn calf serum and 0.1% ethanol (control), or in medium contammg the indicated 
concentrations of dexamethasone for 96 h. Cells were then harvested for cell counting and for assay of heat-stable alkaline phosphatase The data 
represent mean ? S.E.M. of three experiments. 
This allowed us to determine the length of time at 65” C 
needed to destroy intestinal alkaline phosphatase activ- 
ity. We found, by heating extracts of HeLaS3 cells to 
65°C for varying lengths of time, that approximately 
60% of alkaline phosphatase activity in HeLaS3 cells is 
attributable to heat-stable PLAP activity and the re- 
maining 40% of activity had the heat-lability (destroyed 
by 15 min at 65°C) characteristic of intestinal alkaline 
phosphatase activity. In the following experiments cell 
extracts were heated to 65°C for 20 min to ensure only 
PLAP activity was measured. 
3.2. Compounds which induce PLAP activity cause a 
decrease in cell prolijkration 
We studied the effect of varying the concentration of 
butyrate, dexamethasone (a synthetic glucocorticoid), 
bromodeoxyuridine and dibutyryl CAMP on PLAP ac- 
tivity and cell growth. We also measured cell viability 
of HeLaS3 cells grown in the maximal concentrations 
of these compounds. The viability of the cells varied 
between 89-97%. Therefore the observed reductions in 
cell number were not the consequence of a decreased cell 
viability. 
Figs. 14 show the results of these experiments. From 
these figures one can see that in each case there is an 
inverse correlation between PLAP activity and cell 
number (and therefore in growth rate). In each case the 
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graphs of cell number against agent concentration form 
an almost perfect mirror image of the PLAP activity 
versus agent concentration graphs. We applied statisti- 
cal analysis to these data by plotting activity versus 
l/cell number on a scatter plot and found the correla- 
tion coefficients of these graphs varied between 0.680 
and 0.951, indicating a high degree of correlation be- 
tween PLAP activity and cell growth rate. 
3.3. Mimosine u compound which arrests the cell cycle 
in GI induces PLAP activit? 
Butyrate and prednisolone have previously been 
shown to block the cell cycle in Gl phase [11,13]. Since 
we had data indicating that these compounds also in- 
duce PLAP activity we decided to test whether another 
compound known to arrest the cell cycle in Gl would 
cause a corresponding induction in PLAP activity. We 
used the compound mimosine (a-amino-/3-(3-hydroxy- 
4-oxo- 1,4,dihydropyridine- 1 -yl)propanoic acid) which 
is a plant amino acid that inhibits cell cycle traverse in 
late Gl, prior to the onset of DNA synthesis [14,15]. 
The results of this experiment are shown in Table I and 
demonstrate that mimosine totally inhibits growth of 
HeLaS3 cells while only causing a slight decrease in cell 
viability. At the same time this compound caused an 
increase in PLAP activity of up to 230%. 
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Figure 3 Effect of concentration of bromodeoxyuridine on placental alkaline pbosphatase 
activity and cell growth rate of HeLaS3 cells. 
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Fig. 3. HeLaS3 cells were seeded into 75 cm’ flasks at approx. 8 x lo” cells/flask and allowed to attach over a 24 h period. They were then grown, 
either in the absence (control) or presence of bromodeoxyuridine, at the Indicated concentrations, for 6 days. Cells were then harvested for cell 
counting and for assay of heat-stable alkaline phosphatase activity. The medium was changed every 24 h. The data represent mean + S.E.M. of 
three experiments. 
3.4. EGF increases growth rate of HeLaS3 cells and 
causes a cell density-dependent decrease in PLAP 
activity 
We next investigated whether the inverse correlation 
between cell growth rate and PLAP activity would be 
maintained when the growth of HeLaS3 cells was stim- 
Table I 
Effects of mimosine on cell growth and placental alkaline phosphatase 
activity of HeLaS3 cells 
Culture time 
(b) 
Cell number PLAP actlvlty 
(‘X control) 
- 
control +mimosme control +minosme 
24 94.7 f 2.4 43.0 f 2.2 lOOk 2 175 + 7.5 
48 131 + 14.9 44.3 + 2.3 150 + 17.5 275 * 25 
72 140 f 14.2 44.5 + 3.2 325 + 25 750 + 150 
HeLaS3 cells were seeded a& 44 x lo5 cells/75 cm’ flask and incubated 
for 12 h prior to growth in the absence (control) or presence of 400 
PM mimosme, for the Indicated times. Cells were harvested for count- 
ing, viability measurement and assay of PLAP activity. Results arc 
presented as cell number ( x IO-‘) and as % of control enzyme activity 
(where control activity at 24 h IS taken to be 100%) + S.E.M. of three 
experiments. Viabihty of cells grown in the presence of mimosine was 
92% at 24 h, 89% at 48 h and 88% at 72 h. 
ulated by a growth factor. To determine this we grew 
HeLaS3 cells in serum free medium in the absence and 
presence of EGF. We measured the increase in cell num- 
ber at various times after the addition of EGF and at 
the same time measured PLAP activity. 
The growth response of HeLaS3 cells to EGF is 
shown in Fig. 5a. This graph shows that EGF at a 
concentration of 20 nglml significantly increases the 
growth rate of HeLaS3 cells. Cells still grew in the ab- 
sence of EGF, but at a considerably slower rate than in 
its presence. Fig. 5b shows the corresponding PLAP 
activities of the same cells used in the experiments repre- 
sented in Fig. 5a. This shows that after an initial 24 h 
of growth in the presence of EGF there was no measur- 
able decrease in PLAP activity. but between the 2nd and 
4th days of culture there was a small, measurable de- 
crease in PLAP activity. We wondered whether the fact 
that there was no decrease in PLAP act.ivity over the 
initial 24 h period in the presence of EGF might be due 
to the lower cell density of these cells, that is whether 
the decrease in activity observed in the presence of EGF 
was cell density-dependent. To test this idea we repeated 
the experiment, seeding the cells at the higher density of 
3 x lo6 cells/flask. The experiment was performed in 
triplicate and gave the following results: control activity 
(at 24 h) -- 0.0047 +_ 0.0004 unitslmg and +EGF (at 24 
h) - 0.0037 -t 0.0002 units/mg. These results suggest 
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Figure 4 Effect of concentration of dibutyryl cAMPon placental alkaline phosphatase activity 
and cell growth rate of HeLaS3 cells. 
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Fig. 4. HeLaS3 cells were sseeded into 75 cm’ flasks at approx. 8 x 10’ ceils/flask and allowed to attach over a 24 h period. They were then grown, 
either in the absence (control) or presence of dibutyryl CAMP, at the Indicated concentrations, for 72 h. Cells were then harvested for cell counting 
and for assay of heat-stable alkaline phosphatase actlvlty. The medmm was changed every 24 h. The data represent mean + S E.M of three 
experiments. 
that the reduction of PLAP activity observed when 
HeLaS3 cells are grown in the presence of EGF is in- 
deed cell density-dependent. 
4. DISCUSSION 
We have presented data which show that there is an 
inverse correlation between cell growth rate and PLAP 
activity in HeLaS3 cervical cancer cells. We base this 
conclusion on three lines of evidence, firstly we have 
shown that four compounds that induce phosphatase 
activity cause a coincidental, dose-dependent, decrease 
in growth rate, secondly we have shown that mimosine, 
a compound which prevents cell growth by arresting the 
cell cycle in Gl phase, simultaneously increases PLAP 
activity and thirdly we have shown that increasing the 
growth rate of HeLaS3 cells, by culturing them in the 
presence of EGF. causes a concomitant decrease in 
PLAP activity. This decrease in PLAP activity seemed 
to be cell density-dependent. 
As yet this is simply a correlation and it is not possible 
to say exactly how these two variables are connected. 
Thus, we cannot say whether it is the increase in PLAP 
activity which somehow brings about a decrease in 
growth rate, or whether the reverse is true. that is 
whether a decrease in growth rate in some way triggers 
an increase in PLAP activity. It is tempting to see signif- 
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icance in the reported protein phosphotyrosyl phos- 
phatase activity of alkaline phosphatases [6,8] since 
stimulation of cell growth rate by certain growth factors 
is recognized as being accompanied by an increase in 
protein phophotyrosine kinase activity [16]. The EGF 
receptor belongs to a class of hormone/growth factor 
receptors that possess tyrosine kinase activity [17]. The 
suggestion would therefore be that, if stimulation of cell 
division rate involves an intracellular signalling mecha- 
nism requiring increased tyrosine kinase activity, it 
would seem logical if decreased cell division involved 
increased protein tyrosine dephosphorylation [ 181. 
On the other hand the increase in PLAP activity 
might be a consequence rather than a cause of decreased 
cell proliferation. It is a general observation, in both 
normal and neoplastic cellular systems, that there is a 
correlation between increased state of differentiation 
and decreased tendency to undergo cell division. Several 
of the agents that induce PLAP in cultured cells are also 
capable of inducing the differentiation of cells in vitro 
[19,20]. The induction of differentiation in vitro of nor- 
mal human neutrophils and of murine B cells has been 
shown to be accompanied by increased alkaline phos- 
phatase levels [21.22]. Cellular differentiation is the con- 
sequence of changes in the array of genes that are ex- 
pressed in a cell. The induction of PLAP activity in 
HeLa cells has been shown to involve increases in PLAP 
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Figure 5 Effect of EGF on (a) cell growth rate and (b) placental alkaline phosphatase activity 
of He&S3 cells 
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Fig. 5. HeLaS3 cells suspended in MEM containing 2.5% FCS were seeded into nine 75 cm’ flasks to give approx. 16 x 10’ cells/flask. Following 
a period of 24 h, to allow attachment. he cells were washed 3 times in PBS. before addition of serum-free medium. The cells were grown in serum 
free medium for 24 h after which time they were grown, either m the absence (control) or presenee of 20 r&ml EGF. Cells were harvested every 
24 h (a) for cell counting and (b) for heat-stable alkaline phosphatase assay. The data represent mean + S.E.M. of three experiments. 
mRNA, presumably as a result of increased gene tran- 
scription [9,23]. 
Our findings therefore may be seen as establishing a 
clear link between expression of the placental alkaline 
phosphatase gene and rate of cell division. It is not as 
yet possible to be certain what is the nature of this 
connection but one possibility is that, by virtue of its 
protein tyrosine phosphatase activity, PLAP may be a 
crucial component of the growth regulatory mecha- 
nism. 
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